Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron deficiency and heart failure (Inofer ferrosuccinate uptake study)
2018-000874-31Phase 2Completed
- Sponsor
- Mimer Medical
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ferrous succinate in iron deficiency anemia (IDA) and heart failure (HF), sponsored by Mimer Medical. Primary endpoint: Iron uptake of ferrosuccinate (Inofer) over three months. Started Mar 2018; status: completed.
02
Drugs
ferrous succinate
03
Conditions
iron deficiency anemia (IDA)heart failure (HF)
Beyond the preview
Go deeper on 2018-000874-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000874-31.